Sunday, August 2, 2026

Billie Eilish and Zico: A Musical Match Made in Seoul!

According to a News1 report on the...

U.S. Costco Orders Surge Ninefold… Samlip Cheesecake Expands to 300 Stores Nationwide

Samlip's cheese cake sold out 560,000 units in three weeks at Costco, expanding its presence across the U.S. stores.

KCC Glass Unveils Award-Winning Glass Antenna Technology for Future Mobility

KCC Glass wins Best Paper Award for innovative vehicle glass-integrated antenna technology, outperforming major global companies.

News1

How Anthropic’s Mythos AI Exposed Security Flaws in U.S. Government Systems in Just Hours

Anthropic's AI model identified security flaws in classified systems, raising concerns amid tensions with the U.S. government.

Micron Surges Ahead: How AI Memory Chip Demand Boosts Profit Margins to 84.9%

Micron Technology's record 84.9% gross margin outshines competitors, driven by AI demand, signaling a new era for memory semiconductors.

LS GreenLink Targets Commercial Production by 2028 at America’s Largest Submarine Cable Manufacturing Hub

LS Cable & System's U.S. subsidiary begins construction of a major underwater cable plant in Virginia, enhancing energy infrastructure.

Is BTGEN the Next Big Player in Biopharmaceuticals? Discover Their Unique CDMO Strategy

BTGEN is expanding its CDMO business with National Growth Fund support, focusing on innovative processes instead of competing on scale.

K-Bio’s Global Leap: How Korea’s Biotech is Shaping Asia’s Innovation Hub

The BIO USA 2026 highlighted Korea's biotech growth, emphasizing the need for increased capital to enhance global competitiveness.

K-Beauty Shines at BIO USA 2026: Discover the Future of Bio-Integrated Skincare!

K-Beauty showcased its biotech innovations at BIO USA 2026 with a pop-up store, attracting global attention and business opportunities.

Samsung Biologics Expands Global Reach: New European Sales Office Set to Boost Biopharmaceuticals Market

Samsung Biologics expands its global sales network with a new office in Europe, aiming for growth in production and portfolio diversification.

Gilead Launches CAR-T Therapy Yescarta in Korea, Offering Fourfold Survival Benefit for Relapsed or Refractory Lymphoma Patients

Yescarta is widely used for second-line treatment in patients with very low survival rates, and should be adopted as a standard treatment in Korea.

ST Pharm Targets Next-Generation RNA Therapies, Positions Itself as Key CDMO Partner at BIO USA

The RNA therapeutics market is evolving, with ST Pharm aiming to lead in precision manufacturing and targeted delivery for next-gen therapies.

“Cheers” in San Diego: K-Biopharma Showcases Growing Global Influence at BIO USA Networking Event

KPBMA supports Korean pharma's global expansion at BIO USA, boosting international interest and partnerships in the biotech sector.

Korean Biopharma Takes Center Stage at BIO USA as Industry Giants and Biotechs Expand Global Reach

The BIO USA 2026 convention gathers over 20,000 bio industry professionals, highlighting the growing presence of Korean companies.

How AI is Revolutionizing Drug Development: Insights from BIO International Convention 2026

The 2026 BIO International Convention focuses on AI, shifting from technology introduction to validating business outcomes.

Dong-A ST Eyes Early-Stage Licensing Deals as Key Growth Strategy, Says VP Oh Yoon-seok [BIO USA]

Dong-A ST aims for global expansion by licensing preclinical drug candidates, focusing on timely execution of R&D strategies by 2027.

Alteogen CEO Says Additional Licensing Deals Near Completion, Highlights Patent Strength [BIO USA]

Alteogen is nearing global licensing deals, focusing on maximizing value and expanding its platform technology in biopharma.

Top News

- Our Sponsors Ad -

Follow us